Whipple’s disease unmasked by TNF inhibitor therapy for treatment of seronegative rheumatoid arthritis-Reference-Cited by-同舟云学术

Whipple’s disease unmasked by TNF inhibitor therapy for treatment of seronegative rheumatoid arthritis

Published:2022-07 Issue:7 Volume:15 Page:e250693
ISSN:1757-790X
Container-title:BMJ Case Reports
language:en
Short-container-title:BMJ Case Rep

Author:

Mohammed Fahad^ORCID,Kurtom Muhannad,Brant Andrew,Sampath Rahul

Abstract

We report a patient with seronegative rheumatoid arthritis diagnosed with Whipple’s disease following treatment of tumour necrosis factor inhibitor (TNFI) therapy. Whipple’s disease should be considered in patients with seronegative rheumatoid arthritis and other unexplained multisystem illness. The TNFI therapy and immunosuppressive therapies can unmask latent Whipple’s disease.

Publisher

BMJ

Subject

General Medicine

Reference15 articles.

1. Whipple's disease and Tropheryma whipplei infections: from bench to bedside;Boumaza;Lancet Infect Dis,2022

2. Systematic review: Whipple's disease (Tropheryma whipplei infection) and its unmasking by tumour necrosis factor inhibitors;Marth;Aliment Pharmacol Ther,2015

3. Identification of the Uncultured Bacillus of Whipple’s Disease

4. Epidemiology of Whipple's disease in the USA between 2012 and 2017: a population-based national study;Elchert;Dig Dis Sci,2019

5. Rheumatological features of Whipple disease;Tison;Sci Rep,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacillus coagulans BACO-17 ameliorates in vitro and in vivo progression of Rheumatoid arthritis;International Immunopharmacology;2024-11

2. Fever and Increased Gastrointestinal Uptake on Positron Emission Tomography after Anti-Tumour Necrosis Factor Therapy: A Case Report of Whipple’s Disease;Case Reports in Gastroenterology;2024-04-20